NEVA GULSBY: Open Payments
NPI 1639421217 · AUBURN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$865 in 31 payments from 12 companies in 2025. Trend: 2023 $777 · 2024 $583 · 2025 $865
Food & beverage: $865
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $192 |
| ABBVIE INC. | 9 | $141 |
| Abbott Laboratories | 1 | $139 |
| Ardelyx, Inc. | 1 | $132 |
| PFIZER INC. | 3 | $63 |
| SANOFI-AVENTIS U.S. LLC | 2 | $48 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Novo Nordisk Inc | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Corium, LLC | 1 | $20 |
Products named: PROCLAIM, IBSRELA, QULIPTA, NURTEC ODT, VRAYLAR, TZIELD, OTEZLA, Auvelity.
Industry payments across AL — which companies pay providers there.
